Renin-angiotensin system and hemangioblast development from human embryonic stem cells

Expert Review of Hematology

Volumn 2, Issue 2, 2009, Pages 137-143

  Slukvin, Igor I ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Angiotensin converting enzyme; Hemangioblast; Hematopoietic stem cells; Human embryonic stem cells; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; BONE MORPHOGENETIC PROTEIN 4; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; LOSARTAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BB9; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL RENEWAL; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ERYTHROCYTOSIS; HEMANGIOBLAST; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NOTE; PHENOTYPE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 77953379024     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.09.4     Document Type: Note

References (68)

1. Zambidis ET, Soon Park T, Yu W et al. Expression of angiotensin- converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112, 3601-3614 (2008).
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
3. Kaufman DS, Lewis RL, Hanson ET et al. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood 103, 1325-1332 (2004).
4. Mikkola HK, Orkin SH. The journey of developing hematopoietic stem cells. Development 133, 3733-3744 (2006).
5. Maximow AA. Relation of blood cells to connective tissues and endothelium. Physiol. Rev. 4, 533-563 (1924).
6. Sabin F. Origin and development of the primitive vessels of the chick and of the pig. Carnegie Inst. Wash. Publ. Contribs Embryol. 6, 61-124 (1917).
7. Murray PDF. The development in vitro of the blood of the early chick embryo. Proc. Royal Soc. Lond. Series B111, 497-521 (1932).
8. Kennedy M, Firpo M, Choi K et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386, 488-493 (1997).
9. Choi K, Kennedy M, Kazarov A et al. A common precursor for hematopoietic and endothelial cells. Development 125, 725-732 (1998).
10. Yamashita J, Itoh H, Hirashima M et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96 (2000).
11. Kennedy M, D'Souza SL, Lynch-Kattman M et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109, 2679-2687 (2007).
12. Wang L, Li L, Shojaei F et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21, 31-41 (2004).
13. Fehling HJ, Lacaud G, Kubo A et al. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130, 4217-4227 (2003).
14. Ramshaw HS, Haylock D, Swart B et al. Monoclonal antibody BB9 raised against bone marrow stromal cells identifies a cell-surface glycoprotein expressed by primitive human hemopoietic progenitors. Exp. Hematol. 29, 981-992 (2001).
15. Jokubaitis VJ, Sinka L, Driessen R et al. Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 111, 4055-4063 (2008).
16. Sauvageau G, Iscove NN, Humphries RK. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 23, 7223-7232 (2004).
17. Kaufman DS, Hanson ET, Lewis RL et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci USA 98, 10716-10721 (2001).
18. Vodyanik MA, Bork JA, Thomson JA et al. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105, 617-626 (2005).
19. Zambidis ET, Peault B, Park TS et al. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 106, 860-870 (2005).
20. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
21. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
22. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
23. Kondo M, Wagers AJ, Manz MG et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759-806 (2003).
24. Cumano A, Ferraz JC, Klaine M et al. Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity 15, 477-485 (2001).
25. Medvinsky AL, Samoylina NL, Muller AM et al. An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature 364, 64-67 (1993).
26. Gekas C, Dieterlen-Lievre F, Orkin SH et al. The placenta is a niche for hematopoietic stem cells. Dev. Cell 8, 365-375 (2005). (Pubitemid 40309807)
27. Zovein AC, Hofmann JJ, Lynch M et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 3, 625-636 (2008).
28. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19, 1129-1155 (2005).
29. Lensch MW, Daley GQ. Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells. Blood 107, 2605-2612 (2006).
30. Olsen AL, Stachura DL, Weiss MJ. Designer blood: creating hematopoietic lineages from embryonic stem cells. Blood 107, 1265-1275 (2006).
31. Tian X, Woll PS, Morris JK et al. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 24, 1370-1380 (2006). (Pubitemid 44464705)
32. Wang L, Menendez P, Shojaei F et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J. Exp. Med. 201, 1603-1614 (2005).
33. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661-680 (2008).
34. Doetschman TC, Eistetter H, Katz M et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27-45 (1985).
35. Burt RK, Verda L, Kim DA et al. Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J. Exp. Med. 199, 895-904 (2004).
36. Narayan AD, Chase JL, Lewis RL et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 107, 2180-2183 (2006).
37. Ledran MH, Krassowska A, Armstrong L et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3, 85-98 (2008).
38. Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoidmyeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109, 29-37 (2002).
39. Kyba M, Perlingeiro RC, Hoover RR et al. Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5. Proc. Natl Acad. Sci. USA 100(Suppl. 1), 11904-11910 (2003).
40. Perlingeiro RC, Kyba M, Daley GQ. Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid and adult lymphoid-myeloid potential. Development 128, 4597-4604 (2001).
41. Wang Y, Yates F, Naveiras O et al. Embryonic stem cell-derived hematopoietic stem cells. Proc. Natl Acad. Sci. USA 102, 19081-19086 (2005).
42. Comte L, Lorgeot V, Volkov L et al. Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-NSer-Asp-Lys-Pro concentrations. Eur. J. Clin. Invest. 27, 788-790 (1997).
43. Chisi JE, Wdzieczak-Bakala J, Thierry J et al. Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures. Stem Cells 17, 339-344 (1999).
44. Rell K, Koziak K, Jarzyo I et al. Correction of posttransplant erythrocytosis with enalapril. Transplantation 57, 1059-1063 (1994).
45. Nomura S, Sugihara T, Tomiyama T et al. Polycythaemia vera: response to treatment with angiotensin-converting enzyme inhibitor. Eur. J. Haematol. 57, 117-119 (1996).
46. Lenfant M, Wdzieczak-Bakala J, Guittet E et al. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc. Natl Acad. Sci. USA 86, 779-782 (1989).
47. Rousseau A, Michaud A, Chauvet MT et al. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270, 3656-3661 (1995).
48. Cole J, Ertoy D, Lin H et al. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J. Clin. Invest. 106, 1391-1398 (2000).
49. Savary K, Michaud A, Favier J et al. Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo. Blood 105, 103-110 (2005).
50. Grant MB, May WS, Caballero S et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8, 607-612 (2002).
51. Bailey AS, Jiang S, Afentoulis M et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 103, 13-19 (2004).
52. Vodyanik MA, Thomson JA, Slukvin, II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108, 2095-2105 (2006).
53. Qiu C, Hanson E, Olivier E et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp. Hematol. 33, 1450-1458 (2005).
54. Lu SJ, Feng Q, Park JS et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 112, 4475-4484 (2008).
55. Ma F, Ebihara Y, Umeda K et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc. Natl Acad. Sci. USA 105, 13087-13092 (2008).
56. Gaur M, Kamata T, Wang S et al. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J. Thromb. Haemost. 4, 436-442 (2006).
57. Takayama N, Nishikii H, Usui J et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111, 5298-5306 (2008).
58. Saeki K, Nakahara M, Matsuyama S et al. A feeder-free and efficient production of functional neutrophils from human embryonic stem cells. Stem Cells 27(1), 59-67 (2009).
59. Karlsson KR, Cowley S, Martinez FO et al. Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp. Hematol. 36, 1167-1175 (2008).
60. Senju S, Hirata S, Matsuyoshi H et al. Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells. Blood 101, 3501-3508 (2003).
61. Slukvin, II, Vodyanik MA, Thomson JA et al. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J. Immunol. 176, 2924-2932 (2006).
62. Woll PS, Martin CH, Miller JS et al. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J. Immunol. 175, 5095-5103 (2005).
63. Galic Z, Kitchen SG, Kacena A et al. T lineage differentiation from human embryonic stem cells. Proc. Natl Acad. Sci. USA 103, 11742-11747 (2006).
64. Lu SJ, Feng Q, Caballero S et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat. Methods 4, 501-509 (2007).
65. D'Souza SL, Elefanty AG, Keller G. SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. Blood 105, 3862-3870 (2005).
66. Choi KD, Yu J, Smuga-Otto K, Salvagiotto G et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27(3), 559-567 (2009).
67. Okita K, Nakagawa M, Hyenjong H et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953 (2008).
68. Stadtfeld M, Nagaya M, Utikal J et al. Induced pluripotent stem cells generated without viral integration. Science 322, 945-949 (2008).